Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.
about
Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic ApplicationsBioreducible polymers for therapeutic gene deliverySafety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor modelConstruction of a tumor cell-targeting non-viral gene delivery vector with polyethylenimine modified with RGD sequence-containing peptide.Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.Polymer-based delivery of glucagon-like Peptide-1 for the treatment of diabetes.Polymeric oncolytic adenovirus for cancer gene therapy.Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapyCombined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.The functions and applications of RGD in tumor therapy and tissue engineering.Retargeting of gene expression using endothelium specific hexon modified adenoviral vector.Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.A direct comparison of tumor angiogenesis with ⁶⁸Ga-labeled NGR and RGD peptides in HT-1080 tumor xenografts using microPET imaging.Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.Efficient lung orthotopic tumor-growth suppression of oncolytic adenovirus complexed with RGD-targeted bioreducible polymer.Cyclam-based polymeric copper chelators for gene delivery and potential PET imaging.RGD Peptide-Pegylated PLLA Nanoparticles Containing Epirubicin Hydrochloride Exhibit Receptor-Dependent Tumor Trafficking In Vitro and In Vivo.Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX.Poly(disulfide)sNoncovalent Polymer-Gatekeeper in Mesoporous Silica Nanoparticles as a Targeted Drug Delivery Platform
P2860
Q26776553-78365BDC-D3F3-4460-A49E-4F086FC5AFD1Q34079568-30DE801F-19E1-4EC5-A422-26ED982046F3Q34959758-3F93B60C-B210-49C8-B12F-7D17ACEB307DQ35084305-8AE9EE71-C60B-4095-918D-EF046DE27E05Q35624010-5F84C774-268C-43C6-AE9C-2874385ABCC5Q35869766-0C105C64-87B7-4B67-B9A4-95CE487D463DQ36014423-2BCF9B25-F19D-48E5-A5CE-FAF9344A5B0AQ36344901-3E310C13-AB67-484D-A1F9-68296E392746Q36395971-403BEA42-7055-4792-AE4E-E686ACEEEB83Q36879787-0958C71A-6FA8-45B4-8F78-11B063905D4AQ37091818-8B6C54A3-5D8F-4E6B-910F-652D17AF6E1BQ37490265-3C3B599A-C56B-45DC-97C6-B327AAF5F427Q38451918-719D56CB-E2ED-4952-AC67-9B4B59C86E55Q38769919-CC11BACF-5AC5-4159-B6D1-CD19EB7BD045Q38848060-57E7ABCF-9702-45BF-977D-D24010642303Q38978559-D1CBC21A-D278-4AAD-8DE8-B5747A4FFE44Q38988571-E01E38E9-EEFA-40EF-BAC5-39F3B76527E0Q39018330-8AD648CC-035F-4215-985B-27F569759EF6Q39548350-EDF0BB42-F952-43C7-8BFD-382E3EA412D5Q51017351-3629CC99-EE25-4CB8-974A-2AE8E4F83433Q54978842-8CC0796B-15DC-456C-B1C6-31AF0586CE34Q57903047-1439F6C4-B83B-46A4-AAB8-4938FB2F72D4Q58136112-3546EC5C-4A40-44FE-AE25-5060984CD644
P2860
Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@ast
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@en
type
label
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@ast
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@en
prefLabel
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@ast
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@en
P2093
P2860
P1433
P1476
Active targeting of RGD-conjug ...... ssing shRNA against IL-8 mRNA.
@en
P2093
Hye Yeong Nam
Jaesung Kim
Jihoon Ryu
Pyung-Hwan Kim
Sung Wan Kim
Tae-Il Kim
P2860
P304
P356
10.1016/J.BIOMATERIALS.2011.03.084
P50
P577
2011-04-30T00:00:00Z